We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
-1.32%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$417M
AUM Growth
-$24.5M
(-5.6%)
Cap. Flow
-$15.1M
Cap. Flow
% of AUM
-3.63%
Top 10 Holdings %
Top 10 Hldgs %
23.16%
Holding
1,096
New
51
Increased
294
Reduced
328
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$7.46M |
| 2 |
Linde
LIN
|
+$6.13M |
| 3 |
Logitech
LOGI
|
+$3.75M |
| 4 |
Coca-Cola
KO
|
+$1.49M |
| 5 |
Amazon
AMZN
|
+$990K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$14.3M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
+$7.54M |
| 3 |
Alcon
ALC
|
+$5.41M |
| 4 |
Ferrari
RACE
|
+$5.16M |
| 5 |
CNH
CNH Industrial
CNH
|
+$2.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.48% |
| 2 | Technology | 15.28% |
| 3 | Consumer Discretionary | 11.12% |
| 4 | Healthcare | 10.96% |
| 5 | Industrials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Quest Diagnostics
DGX
$25.1B
| $871K | 0.21% |
5,994
+440
| +8% | +$64.4K |
|
|
MRSH
102
Marsh
MRSH
$86.3B
| $863K | 0.21% |
+5,700
| New | +$862K |
|
103
Airbnb
ABNB
$83.7B
| $863K | 0.21% |
5,142
-299
| -5% | -$45.7K |
|
104
MetLife
MET
$61B
| $855K | 0.21% |
13,856
+286
| +2% | +$17.2K |
|
105
Pfizer
PFE
$140B
| $850K | 0.2% |
19,774
-11,435
| -37% | -$507K |
|
106
Ball Corp
BALL
$17B
| $839K | 0.2% |
9,328
+9,326
| +466,300% | +$827K |
|
107
Clean Harbors
CLH
$16.1B
| $833K | 0.2% |
8,024
-2,006
| -20% | -$197K |
|
108
GE Aerospace
GE
$367B
| $830K | 0.2% |
12,932
+6,088
| +89% | +$391K |
|
|
SEE
109
DELISTED
Sealed Air
SEE
| $827K | 0.2% |
15,090
+7,383
| +96% | +$429K |
|
110
Viatris
VTRS
$20.1B
| $821K | 0.2% |
60,585
+60,054
| +11,310% | +$852K |
|
|
K
111
DELISTED
Kellanova
K
| $819K | 0.2% |
13,644
+3,208
| +31% | +$192K |
|
|
AQUA
112
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $808K | 0.19% |
21,511
-11,123
| -34% | -$402K |
|
|
DISCK
113
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $796K | 0.19% |
+32,809
| New | +$877K |
|
114
Jacobs Solutions
J
$15.9B
| $795K | 0.19% |
7,255
+2,719
| +60% | +$301K |
|
115
Organon & Co
OGN
$3.55B
| $793K | 0.19% |
24,184
+19,433
| +409% | +$622K |
|
116
Vulcan Materials
VMC
$36.3B
| $785K | 0.19% |
4,642
-861
| -16% | -$154K |
|
117
Boeing
BA
$165B
| $777K | 0.19% |
+3,534
| New | +$788K |
|
118
Canadian Imperial Bank of Commerce
CM
$107B
| $773K | 0.19% |
13,972
+2,600
| +23% | +$150K |
|
119
Eaton
ETN
$157B
| $767K | 0.18% |
5,134
+514
| +11% | +$82.1K |
|
|
SPAQ.U
120
DELISTED
Spartan Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fo
SPAQ.U
| $764K | 0.18% |
75,000
| – | – |
|
121
Eagle Materials
EXP
$6.6B
| $752K | 0.18% |
5,732
-1,205
| -17% | -$173K |
|
122
American Electric Power
AEP
$73.7B
| $751K | 0.18% |
9,253
+1,189
| +15% | +$104K |
|
123
American Tower
AMT
$77.7B
| $751K | 0.18% |
2,829
+887
| +46% | +$253K |
|
124
JD.com
JD
$40.8B
| $747K | 0.18% |
10,336
+2,815
| +37% | +$208K |
|
125
Archer Daniels Midland
ADM
$41.4B
| $742K | 0.18% |
12,360
+7,290
| +144% | +$437K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q3 2021 Portfolio in Review
As of Q3 2021, Exane Derivatives held 1,096 positions worth $417M, down 5.6% from $441M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Exane Derivatives withdrew a net $15.1M in Q3 2021, closing 50 positions and reducing 328 holdings. Its most notable exit was Kraft Heinz, an estimated $1.62M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Exane Derivatives opened a new position in Discovery, Inc. Series C Common Stock worth $796K.
- Exane Derivatives's largest Q3 2021 buy was Discovery, Inc. Series C Common Stock: 32,809 shares worth $796K.
- Exane Derivatives added most to UBS Group in Q3 2021, an estimated $7.46M increase.
- Exane Derivatives's biggest Q3 2021 reduction was Stellantis, cutting an estimated $14.3M.
- Exane Derivatives fully exited Kraft Heinz in Q3 2021, selling an estimated $1.62M.
- Exane Derivatives's ten largest holdings make up 23% of its $417M portfolio in Q3 2021.
- Exane Derivatives opened 51 new positions and closed 50 in Q3 2021.
- Exane Derivatives's portfolio value fell 5.6% quarter-over-quarter to $417M.
Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.